Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 25.60%6.84B | -12.95%13.34B | -27.22%5.45B | 27.95%15.33B | 34.32%7.49B | 2.05%11.98B | -0.32%5.57B | 32.46%11.74B | 67.21%5.59B | -21.12%8.86B |
| Operating income | 25.60%6.84B | -12.95%13.34B | -27.22%5.45B | 27.95%15.33B | 34.32%7.49B | 2.05%11.98B | -0.32%5.57B | 32.46%11.74B | 67.21%5.59B | -21.12%8.86B |
| Cost of sales | -21.90%-4.47B | 19.97%-8.92B | 32.15%-3.67B | -27.48%-11.15B | -31.28%-5.4B | -2.86%-8.75B | -0.62%-4.12B | -36.52%-8.5B | -83.15%-4.09B | 21.26%-6.23B |
| Operating expenses | -21.90%-4.47B | 19.97%-8.92B | 32.15%-3.67B | -27.48%-11.15B | -31.28%-5.4B | -2.86%-8.75B | -0.62%-4.12B | -36.52%-8.5B | -83.15%-4.09B | 21.26%-6.23B |
| Gross profit | 33.20%2.37B | 5.81%4.42B | -14.40%1.78B | 29.22%4.17B | 42.93%2.08B | -0.11%3.23B | -2.89%1.46B | 22.85%3.23B | 35.13%1.5B | -20.79%2.63B |
| Selling expenses | -15.31%-1.12B | -9.29%-2.23B | -1.12%-968.06M | -23.59%-2.04B | -27.75%-957.37M | -1.67%-1.65B | 3.46%-749.41M | -5.38%-1.63B | -7.81%-776.25M | 20.65%-1.54B |
| Administrative expenses | 2.38%-187.52M | -49.51%-379.93M | -69.92%-192.1M | -18.70%-254.11M | -23.79%-113.05M | -13.40%-214.07M | -8.97%-91.32M | -24.92%-188.78M | -13.53%-83.81M | 12.72%-151.12M |
| Impairment and provision | -31.69%-910K | 98.52%-746K | 97.84%-691K | -2,858.57%-50.54M | -3,333.64%-32.01M | 115.53%1.83M | 248.20%990K | 38.14%-11.8M | 96.60%-668K | -203.91%-19.07M |
| -Other impairment is provision | -31.69%-910K | 98.52%-746K | 97.84%-691K | -2,858.57%-50.54M | -3,333.64%-32.01M | 115.53%1.83M | 248.20%990K | 38.14%-11.8M | 96.60%-668K | -203.91%-19.07M |
| Special items of operating profit | -241.88%-288.92M | -235.10%-390.98M | -152.39%-84.51M | 36.85%289.39M | -20.12%161.32M | -10.51%211.46M | 43.14%201.97M | -27.37%236.3M | 55.27%141.09M | 583.05%325.35M |
| Operating profit | 45.38%779.65M | -33.26%1.41B | -52.97%536.3M | 34.23%2.12B | 39.33%1.14B | -4.08%1.58B | 4.94%818.46M | 32.08%1.64B | 101.47%779.93M | 7.64%1.24B |
| Financing income | -27.09%11.31M | -8.51%26.51M | 7.75%15.52M | -12.52%28.98M | -20.79%14.4M | -62.08%33.13M | -61.11%18.18M | 37.77%87.34M | 48.85%46.75M | 39.49%63.4M |
| Financing cost | -47.84%-41.24M | 0.80%-59.12M | -61.48%-27.89M | -187.03%-59.6M | -85.67%-17.27M | 10.11%-20.76M | 7.77%-9.3M | 19.94%-23.1M | 46.06%-10.09M | 54.26%-28.85M |
| Share of profits of associates | ---- | ---- | ---- | ---- | ---- | 2.90%-23.15M | -148.19%-23.15M | -2.64%-23.84M | 72.32%-9.33M | 50.67%-23.23M |
| Earning before tax | 43.10%749.73M | -33.84%1.38B | -53.94%523.93M | 33.19%2.09B | 41.44%1.14B | -7.02%1.57B | -0.38%804.19M | 34.11%1.68B | 120.48%807.26M | 15.07%1.26B |
| Tax | -39.24%-148.54M | 4.76%-311.59M | 45.24%-106.68M | -16.57%-327.17M | -32.90%-194.83M | 3.65%-280.66M | 4.42%-146.6M | -23.27%-291.3M | -109.71%-153.37M | -5.77%-236.3M |
| After-tax profit from continuing operations | 44.09%601.19M | -39.25%1.07B | -55.74%417.25M | 36.83%1.76B | 43.34%942.63M | -7.73%1.28B | 0.57%657.6M | 36.62%1.39B | 123.17%653.89M | 17.46%1.02B |
| Earning after tax | 44.09%601.19M | -39.25%1.07B | -55.74%417.25M | 36.83%1.76B | 43.34%942.63M | -7.73%1.28B | 0.57%657.6M | 36.62%1.39B | 123.17%653.89M | 17.46%1.02B |
| Minority profit | -4.49%-18M | -238.08%-32.01M | -86,015.00%-17.22M | -31,456.67%-9.47M | 0.00%-20K | -11.11%-30K | -33.33%-20K | -101.50%-27K | -100.83%-15K | 34.55%1.8M |
| Profit attributable to shareholders | 42.52%619.19M | -37.77%1.1B | -53.91%434.47M | 37.56%1.77B | 43.34%942.65M | -7.73%1.28B | 0.57%657.62M | 36.86%1.39B | 124.56%653.9M | 17.43%1.02B |
| Basic earnings per share | 41.89%1.05 | -37.87%1.87 | -54.04%0.74 | 37.44%3.01 | 43.75%1.61 | -7.59%2.19 | 0.90%1.12 | 36.99%2.37 | 122.00%1.11 | 16.89%1.73 |
| Diluted earnings per share | 41.89%1.05 | -37.87%1.87 | -54.04%0.74 | 37.44%3.01 | 43.75%1.61 | -7.59%2.19 | 0.90%1.12 | 36.99%2.37 | 122.00%1.11 | 16.89%1.73 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | PricewaterhouseCoopers | -- | PwC Accounting Firm | -- | PwC Accounting Firm | -- | PricewaterhouseCoopers | -- | PwC Accounting Firm |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.